Accelerated drug approval: Meeting the ethical yardstick
Drugs addressing unmet medical needs can change the lives of millions. Developing and validating new drugs can, however, take many years. To streamline the assessment of new drugs, regulatory agencies have long established shortened review pathways. Among these programs, Accelerated Approval (AA) ha...
| Authors: | ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Wiley-Blackwell
2023
|
| In: |
Bioethics
Year: 2023, Volume: 37, Issue: 7, Pages: 647-655 |
| IxTheo Classification: | KBQ North America NCH Medical ethics NCJ Ethics of science XA Law |
| Further subjects: | B
drug regulation
B Aducanumab B Accelerated Approval B ethics of clinical research |
| Online Access: |
Volltext (kostenfrei) Volltext (kostenfrei) |